Pfizer (PFE)
Company | Ticker | Sector | Industry | Quality | PAR |
---|---|---|---|---|
Pfizer | PFE | Healthcare | Drug Manufacturers - General | 91 | 14.1% |
Current Price ( 3/27 4:00PM EDT) | $27.78 | |||
CAPS Rating (Rate this stock on CAPS) | ||||
Expected Income Statement | ||||
Current Sales | 50,681.8 | |||
Sales Growth Forecast | 5.0% | |||
Net Profit Margin | 30.3% | |||
Projected Shares Outstanding | 5,600.00 | |||
EPS - Five year Forecast | $3.49 | |||
Average P/E Ratio | 13.0 | |||
Projected Average Price | $45.40 | |||
Price Appreciation (Annualized) | 10.3% | |||
Annual Dividend Yield | 3.8% | |||
Projected Annual Return | 14.1% | |||
Quality | ||||
Financial Strength | 79 | 19.7 | ||
EPS Stability | 71 | 17.7 | ||
Industry Sales Growth Rate | 4.0% | 15.5 | ||
Industry Net Profit Margin | 19.3% | 19.6 | ||
Calculated Quality Rating | 72.5 | |||
Fool CAPS | ||||
Total Players
5617
Outperforms
591
Underperforms
All-Stars (947)
871
Outperforms (92%)
76
Underperforms
|
||||
Fundamental Data Updated: 12/29/2023 |